Metabolic syndrome, non-alcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF)
Authors:
- Yasemin H. BalabanYBYasemin H. Balaban
- Hale SumerHSHale Sumer
- Halis SimsekHSHalis Simsek
- Durdal UsDUDurdal Us
- Gonca TatarGTGonca Tatar
Open Access
- 1 April 2006
- journal article
- Published by Elsevier in Annals of Hepatology
- Vol. 5 (2) , 109-114
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Insulin Resistance, the Metabolic Syndrome, and Nonalcoholic Fatty Liver DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2005
- Non-alcoholic steatohepatitisEuropean Journal of Gastroenterology & Hepatology, 2004
- Liver injury in the setting of steatosis: Crosstalk between adipokine and cytokine†Hepatology, 2004
- Comparison of the Release of Adipokines by Adipose Tissue, Adipose Tissue Matrix, and Adipocytes from Visceral and Subcutaneous Abdominal Adipose Tissues of Obese HumansEndocrinology, 2004
- Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic ConferenceHepatology, 2003
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic SyndromeHepatology, 2003
- Nonalcoholic Fatty Liver DiseaseDiabetes, 2001
- Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines · Adipocyte‐derived Bioactive SubstancesAnnals of the New York Academy of Sciences, 1999
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999
- Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence.Journal of the American College of Nutrition, 1997